New Advances in Radiopharmaceutical Sciences
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 5902
Special Issue Editor
Interests: radiopharmaceutical sciences; radiolabeling chemistry; radiometals for medicinal purposes; PET tracers; dosimetry for individualized treatment-planning; nuclide production; automatization
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The different steps of developing radiopharmaceuticals, from the basic idea to their final clinical application (and approval), represent the strongly interdisciplinary character of nuclear medicine.
Preclinical as well as clinical evaluation of any novel radiopharmaceutical (antibodies, peptides, small molecules) deals with all subjects related to the identification of new molecular targets and their specific utilization for efficient nuclear medical imaging and therapy options in a variety of medical conditions such as neurodegenerative or cardiovascular metabolic disorders, cancer or other immune-associated diseases. This includes in vitro and in vivo measurements and modeling of radiotracer binding, distribution and pharmacokinetics as well as dosimetry studies. Sophisticated investigations and advances in clinical research have increasingly opened up new attractive areas of application for radiopharmaceuticals. Examples are the imaging-based patient selection and their use as theranostic tool for a personalized treatment.
The core of the design of a radiopharmaceutical is the choice of the adequate radiochemistry, which includes the choice of the radionuclide due its chemical and physical properties, its production and purification, the choice of suitable labeling strategies and precursors, which takes the chemistry and pharmacokinetics of the target vector into account. All this finally leads to an optimized automated synthesis of pharmaceutical grade radiopharmaceuticals.
The editors of this Special Issue of Molecules welcome all contributions (communications, research papers and review articles) on new advances concerning the manifold facets of radiopharmaceuticals and their development.
Dr. Elisabeth Eppard
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- radiopharmacy/radiopharmaceuticals
- radiochemistry
- radionuclide therapy
- theranostics
- PET
- SPECT
- radiolabeling techniques
- radionuclide production
- nuclear medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.